The Patent Finder

Beyondspring Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Beyondspring Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Beyondspring Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 10,596,169Cancer Treatment with Combination of Plinabulin and Taxane
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,550,104Plinabulin Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,956,058Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
Formerly held
Term ended
Term ended Jan 16, 2026 · From the USPTO record
Term endedTerm ended Jan 16, 2026From the USPTO record
US 7,674,903Dehydrophenylahistins and Analogs Thereof and the Synthesis of Dehydrophenylahistins and Analogs Thereof
Formerly held
Term ended
Term ended Dec 31, 2025 · High confidence
Term endedTerm ended Dec 31, 2025High confidence
US 7,935,704Dehydrophenylahistins and Analogs Thereof and the Synthesis of Dehydrophenylahistins and Analogs Thereof
Term ended
Term ended Nov 10, 2025 · High confidence
Term endedTerm ended Nov 10, 2025High confidence
US 7,064,201Dehydrophenylahistins and Analogs Thereof and the Synthesis of Dehydrophenylahistins and Analogs Thereof
Term ended
Term ended Apr 7, 2024 · High confidence
Term endedTerm ended Apr 7, 2024High confidence
US 7,919,497Analogs of Dehydrophenylahistins and Their Therapeutic Use
Term ended
Term ended Apr 7, 2024 · High confidence
Term endedTerm ended Apr 7, 2024High confidence
US 8,247,552Analogs of dehydrophenylahistins and their therapeutic use
Term ended
Term ended Aug 1, 2023 · From the USPTO record
Term endedTerm ended Aug 1, 2023From the USPTO record
US 8,618,292Analogs of dehydrophenylahistins and their therapeutic use
Term ended
Ended no later than Aug 1, 2023 · From the USPTO record
Term endedEnded no later than Aug 1, 2023From the USPTO record
US 6,972,289Cell Division Inhibitor and a Production Method Thereof
Term ended
Term ended Jun 14, 2021 · High confidence
Term endedTerm ended Jun 14, 2021High confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited